Inscripta, Inc.
Andrew Skulan is currently the Director of Business Development & Head of Alliances at Inscripta, Inc. where Andrew focuses on building B2B partnerships in the personal care and food & nutrition markets. Andrew is also the Co-Founder of 7Sierra Group, a consulting firm specializing in growth strategies for CPG brands. Previously, Andrew held various roles at The Clorox Company, including Associate Director in Corporate Development and M&A. With a background in chemistry and physics, Andrew has been involved in R&D and innovation in consumer packaged goods throughout their career. Additionally, Andrew has served as a Board Member at Naturally Bay Area and worked as a Postdoctoral Researcher at Sandia National Laboratories.
This person is not in any offices
Inscripta, Inc.
Inscripta is developing the world’s first benchtop platform for scalable digital genome engineering. The company’s advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of single cells at an unprecedented scale.